| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.37 | 0.01 |